Response to paper by Douxfils et al. Oestradiol is not the Holy Grail in the quest for the ideal oestrogen therapy.

AMA Bińkowska M, Jakimiuk A, Paszkowski T, Pawelczyk L, Skrzypulec-Plinta V. Response to paper by Douxfils et al. Oestradiol is not the Holy Grail in the quest for the ideal oestrogen therapy. Menopause Review/Przegląd Menopauzalny. 2023. doi:10.5114/pm.2023.131374. APA Bińkowska, M., Jakimiuk, A., Paszkowski, T., Pawelczyk, L., & Skrzypulec-Plinta, V. (2023). Response to paper by Douxfils et al. Oestradiol is not the Holy Grail in the quest for the ideal oestrogen therapy. Menopause Review/Przegląd Menopauzalny. https://doi.org/10.5114/pm.2023.131374 Chicago Bińkowska, Małgorzata, Artur Jakimiuk, Tomasz Paszkowski, Leszek Pawelczyk, and Violetta Skrzypulec-Plinta. 2023. "Response to paper by Douxfils et al. Oestradiol is not the Holy Grail in the quest for the ideal oestrogen therapy". Menopause Review/Przegląd Menopauzalny. doi:10.5114/pm.2023.131374. Harvard Bińkowska, M., Jakimiuk, A., Paszkowski, T., Pawelczyk, L., and Skrzypulec-Plinta, V. (2023). Response to paper by Douxfils et al. Oestradiol is not the Holy Grail in the quest for the ideal oestrogen therapy. Menopause Review/Przegląd Menopauzalny. https://doi.org/10.5114/pm.2023.131374 MLA Bińkowska, Małgorzata et al. "Response to paper by Douxfils et al. Oestradiol is not the Holy Grail in the quest for the ideal oestrogen therapy." Menopause Review/Przegląd Menopauzalny, 2023. doi:10.5114/pm.2023.131374. Vancouver Bińkowska M, Jakimiuk A, Paszkowski T, Pawelczyk L, Skrzypulec-Plinta V. Response to paper by Douxfils et al. Oestradiol is not the Holy Grail in the quest for the ideal oestrogen therapy. Menopause Review/Przegląd Menopauzalny. 2023. doi:10.5114/pm.2023.131374.